FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...